메뉴 건너뛰기




Volumn 48, Issue 9, 2005, Pages 1898-1905

Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells

Author keywords

Apoptosis; Atherosclerosis; Diabetes; Glargine; Human coronary artery endothelial cells; Human coronary artery smooth muscle cells; Insulin; Insulin resistance; Proliferation

Indexed keywords

CASPASE 3; INSULIN; INSULIN GLARGINE; KI 67 ANTIGEN;

EID: 24944566769     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1874-4     Document Type: Article
Times cited : (37)

References (38)
  • 1
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 2
    • 0038131919 scopus 로고    scopus 로고
    • Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial
    • Fritsche A, Schweitzer MA, Haring HU (2003) Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial. Ann Intern Med 138:952-959
    • (2003) Ann Intern Med , vol.138 , pp. 952-959
    • Fritsche, A.1    Schweitzer, M.A.2    Haring, H.U.3
  • 3
    • 0033867021 scopus 로고    scopus 로고
    • Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes
    • Yki-Jarvinen H, Dressler A, Ziemen M, HOE 901/3002 study group (2000) Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23:1130-1136
    • (2000) Diabetes Care , vol.23 , pp. 1130-1136
    • Yki-Jarvinen, H.1    Dressler, A.2    Ziemen, M.3
  • 4
    • 0242269000 scopus 로고    scopus 로고
    • The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • Riddle MC, Rosenstock J, Gerich J (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080-3086
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 6
    • 1042291148 scopus 로고    scopus 로고
    • 3.5 Years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes
    • Vehkavaara S, Yki-Jarvinen H (2004) 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol 24:325-330
    • (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 325-330
    • Vehkavaara, S.1    Yki-Jarvinen, H.2
  • 7
    • 0342657181 scopus 로고    scopus 로고
    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
    • Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999-1005
    • (2000) Diabetes , vol.49 , pp. 999-1005
    • Kurtzhals, P.1    Schaffer, L.2    Sorensen, A.3    Kristensen, C.4    Jonassen, I.5    Schmid, C.6    Trub, T.7
  • 8
    • 4143135494 scopus 로고    scopus 로고
    • Plasma insulin and cardiovascular mortality in non-diabetic European men and women: A meta-analysis of data from eleven prospective studies
    • Diabetologia
    • Diabetologia (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47:1245-1256
    • (2004) Diabetologia , vol.47 , pp. 1245-1256
  • 9
    • 1842334481 scopus 로고    scopus 로고
    • Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients
    • Caixas A, Ordonez-Llanos J, de Leiva A, Payes A, Homs R, Perez A (1997) Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46:1207-1213
    • (1997) Diabetes , vol.46 , pp. 1207-1213
    • Caixas, A.1    Ordonez-Llanos, J.2    De Leiva, A.3    Payes, A.4    Homs, R.5    Perez, A.6
  • 10
    • 0023874485 scopus 로고
    • Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes
    • Taskinen MR, Kuusi T, Helve E, Nikkila EA, Yki-Jarvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8:168-177
    • (1988) Arteriosclerosis , vol.8 , pp. 168-177
    • Taskinen, M.R.1    Kuusi, T.2    Helve, E.3    Nikkila, E.A.4    Yki-Jarvinen, H.5
  • 11
    • 3242797399 scopus 로고    scopus 로고
    • Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises
    • Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53:2079-2086
    • (2004) Diabetes , vol.53 , pp. 2079-2086
    • Stentz, F.B.1    Umpierrez, G.E.2    Cuervo, R.3    Kitabchi, A.E.4
  • 12
    • 0036597085 scopus 로고    scopus 로고
    • The anti-inflammatory and potential anti-atherogenic effect of insulin: A new paradigm
    • Dandona P, Aljada A, Mohanty P (2002) The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924-930
    • (2002) Diabetologia , vol.45 , pp. 924-930
    • Dandona, P.1    Aljada, A.2    Mohanty, P.3
  • 13
    • 0037341759 scopus 로고    scopus 로고
    • Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels
    • Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1082-1088
    • Hansen, T.K.1    Thiel, S.2    Wouters, P.J.3    Christiansen, J.S.4    Van Den Berghe, G.5
  • 14
    • 0024520154 scopus 로고
    • Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I
    • Banskota NK, Taub R, Zellner K, Olsen P, King GL (1989) Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38:123-129
    • (1989) Diabetes , vol.38 , pp. 123-129
    • Banskota, N.K.1    Taub, R.2    Zellner, K.3    Olsen, P.4    King, G.L.5
  • 15
    • 0019990221 scopus 로고
    • Binding and biological actions of insulin-like growth factors on human arterial smooth muscle cells
    • Pfeifle B, Ditschuneit HH, Ditschuneit H (1982) Binding and biological actions of insulin-like growth factors on human arterial smooth muscle cells. Horm Metab Res 14:409-414
    • (1982) Horm Metab Res , vol.14 , pp. 409-414
    • Pfeifle, B.1    Ditschuneit, H.H.2    Ditschuneit, H.3
  • 16
    • 0032878349 scopus 로고    scopus 로고
    • Insulin-like growth factor-1 receptors mediate infragenicular vascular smooth muscle cell proliferation in response to glucose and insulin not by insulin receptors
    • Avena R, Mitchell ME, Carmody B, Arora S, Neville RF, Sidaway AN (1999) Insulin-like growth factor-1 receptors mediate infragenicular vascular smooth muscle cell proliferation in response to glucose and insulin not by insulin receptors. Am J Surg 178:156-161
    • (1999) Am J Surg , vol.178 , pp. 156-161
    • Avena, R.1    Mitchell, M.E.2    Carmody, B.3    Arora, S.4    Neville, R.F.5    Sidaway, A.N.6
  • 17
    • 0036248493 scopus 로고    scopus 로고
    • Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells
    • Yamada H, Tsushima T, Murakami H, Uchigata Y, Iwamoto Y (2002) Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells. Int J Exp Diabetes Res 3:131-144
    • (2002) Int J Exp Diabetes Res , vol.3 , pp. 131-144
    • Yamada, H.1    Tsushima, T.2    Murakami, H.3    Uchigata, Y.4    Iwamoto, Y.5
  • 18
    • 0031894221 scopus 로고    scopus 로고
    • Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels
    • Cruzado M, Risler N, Castro C, Ortiz A, Ruttler ME (1998) Proliferative effect of insulin on cultured smooth muscle cells from rat mesenteric resistance vessels. Am J Hypertens 11:54-58
    • (1998) Am J Hypertens , vol.11 , pp. 54-58
    • Cruzado, M.1    Risler, N.2    Castro, C.3    Ortiz, A.4    Ruttler, M.E.5
  • 19
    • 0033851606 scopus 로고    scopus 로고
    • Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells
    • Kamide K, Hori MT, Zhu JH et al (2000) Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells. J Hypertens 18:1051-1056
    • (2000) J Hypertens , vol.18 , pp. 1051-1056
    • Kamide, K.1    Hori, M.T.2    Zhu, J.H.3
  • 21
    • 0022002617 scopus 로고
    • Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta
    • King GL, Goodman AD, Buzney S, Moses A, Kahn CR (1985) Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036
    • (1985) J Clin Invest , vol.75 , pp. 1028-1036
    • King, G.L.1    Goodman, A.D.2    Buzney, S.3    Moses, A.4    Kahn, C.R.5
  • 22
    • 0020681210 scopus 로고
    • Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels
    • King GL, Buzney SM, Kahn CR et al (1983) Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest 71:974-979
    • (1983) J Clin Invest , vol.71 , pp. 974-979
    • King, G.L.1    Buzney, S.M.2    Kahn, C.R.3
  • 23
    • 2442711785 scopus 로고    scopus 로고
    • Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells
    • Chisalita SI, Arnqvist HJ (2004) Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab 286:E896-E901
    • (2004) Am J Physiol Endocrinol Metab , vol.286
    • Chisalita, S.I.1    Arnqvist, H.J.2
  • 25
    • 0029789432 scopus 로고    scopus 로고
    • Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells
    • Zeng G, Quon MJ (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98:894-898
    • (1996) J Clin Invest , vol.98 , pp. 894-898
    • Zeng, G.1    Quon, M.J.2
  • 26
    • 0033964671 scopus 로고    scopus 로고
    • Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells
    • Hermann C, Assmus B, Urbich C, Zeiher AM, Dimmeler S (2000) Insulin-mediated stimulation of protein kinase Akt: a potent survival signaling cascade for endothelial cells. Arterioscler Thromb Vasc Biol 20:402-409
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 402-409
    • Hermann, C.1    Assmus, B.2    Urbich, C.3    Zeiher, A.M.4    Dimmeler, S.5
  • 27
    • 0037382424 scopus 로고    scopus 로고
    • Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells
    • Eitel K, Staiger H, Rieger J et al (2003) Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 52:991-997
    • (2003) Diabetes , vol.52 , pp. 991-997
    • Eitel, K.1    Staiger, H.2    Rieger, J.3
  • 28
    • 0036739920 scopus 로고    scopus 로고
    • Progression of atheroma: A struggle between death and procreation
    • Geng YJ, Libby P (2002) Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 22:1370-1380
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 1370-1380
    • Geng, Y.J.1    Libby, P.2
  • 29
    • 0036851826 scopus 로고    scopus 로고
    • Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
    • Dzau VJ, Braun-Dullaeus RC, Seeding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249-1256
    • (2002) Nat Med , vol.8 , pp. 1249-1256
    • Dzau, V.J.1    Braun-Dullaeus, R.C.2    Seeding, D.G.3
  • 30
    • 0030956584 scopus 로고    scopus 로고
    • Apoptotic vascular endothelial cells become procoagulant
    • Bombeli T, Karsan A, Tait JF, Harlan JM (1997) Apoptotic vascular endothelial cells become procoagulant. Blood 89:2429-2442
    • (1997) Blood , vol.89 , pp. 2429-2442
    • Bombeli, T.1    Karsan, A.2    Tait, J.F.3    Harlan, J.M.4
  • 31
    • 0032891440 scopus 로고    scopus 로고
    • Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
    • Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348-353
    • (1999) Circulation , vol.99 , pp. 348-353
    • Mallat, Z.1    Hugel, B.2    Ohan, J.3    Leseche, G.4    Freyssinet, J.M.5    Tedgui, A.6
  • 32
    • 0029054734 scopus 로고
    • Molecular bases of the acute coronary syndromes
    • Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91:2844-2850
    • (1995) Circulation , vol.91 , pp. 2844-2850
    • Libby, P.1
  • 33
    • 0344466714 scopus 로고    scopus 로고
    • IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells
    • Jamali R, Bao M, Arnqvist HJ (2003) IGF-I but not insulin inhibits apoptosis at a low concentration in vascular smooth muscle cells. J Endocrinol 179:267-274
    • (2003) J Endocrinol , vol.179 , pp. 267-274
    • Jamali, R.1    Bao, M.2    Arnqvist, H.J.3
  • 34
    • 0035964578 scopus 로고    scopus 로고
    • TNFalpha inhibits insulin's antiapoptotic signaling in vascular smooth muscle cells
    • Goetze S, Blaschke F, Stawowy P et al (2001) TNFalpha inhibits insulin's antiapoptotic signaling in vascular smooth muscle cells. Biochem Biophys Res Commun 287:662-670
    • (2001) Biochem Biophys Res Commun , vol.287 , pp. 662-670
    • Goetze, S.1    Blaschke, F.2    Stawowy, P.3
  • 35
    • 0028903234 scopus 로고
    • Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
    • Bennett MR, Evan GI, Schwartz SM (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95:2266-2274
    • (1995) J Clin Invest , vol.95 , pp. 2266-2274
    • Bennett, M.R.1    Evan, G.I.2    Schwartz, S.M.3
  • 36
    • 0035843913 scopus 로고    scopus 로고
    • Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling
    • Patel VA, Zhang QJ, Siddle K et al (2001) Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 88:895-902
    • (2001) Circ Res , vol.88 , pp. 895-902
    • Patel, V.A.1    Zhang, Q.J.2    Siddle, K.3
  • 37
    • 0034781425 scopus 로고    scopus 로고
    • Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque
    • Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777-1789
    • (2001) J Mol Cell Cardiol , vol.33 , pp. 1777-1789
    • Okura, Y.1    Brink, M.2    Zahid, A.A.3    Anwar, A.4    Delafontaine, P.5
  • 38
    • 1342268345 scopus 로고    scopus 로고
    • Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells
    • Artwohl M, Roden M, Waldhausl W, Freudenthaler A, Baumgartner-Parzer SM (2004) Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 18:146-148
    • (2004) FASEB J , vol.18 , pp. 146-148
    • Artwohl, M.1    Roden, M.2    Waldhausl, W.3    Freudenthaler, A.4    Baumgartner-Parzer, S.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.